Medpace

Medpace

Yahoo Finance • 19 days ago

3 Market-Beating Stocks with Promising Prospects

3 Market-Beating Stocks with Promising Prospects Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost alwa... Full story

Yahoo Finance • 21 days ago

Medpace (MEDP) Outperforms Broader Market: What You Need to Know

In the latest trading session, Medpace (MEDP) closed at $624.20, marking a +1.94% move from the previous day. The stock's change was more than the S&P 500's daily gain of 1.49%. At the same time, the Dow added 0.71%, and the tech-heavy Nas... Full story

Yahoo Finance • 28 days ago

Medpace (MEDP) Ascends While Market Falls: Some Facts to Note

Medpace (MEDP) closed the most recent trading day at $595.41, moving +1.34% from the previous trading session. The stock exceeded the S&P 500, which registered a loss of 0.48% for the day. Elsewhere, the Dow saw a downswing of 0.29%, while... Full story

Yahoo Finance • last month

2 Healthcare Stocks with Competitive Advantages and 1 We Question

2 Healthcare Stocks with Competitive Advantages and 1 We Question Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong fina... Full story

Yahoo Finance • last month

Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich?

Revvity, Inc. RVTY is entering the second half of 2026 with stronger operating momentum. Raised guidance, double-digit Diagnostics growth and better cash generation have improved the earnings setup. The counterweight is valuation. RVTY al... Full story

Yahoo Finance • last month

Teladoc (TDOC) Down 3.3% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for Teladoc (TDOC). Shares have lost about 3.3% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Tel... Full story

Yahoo Finance • 2 months ago

Medpace (MEDP): Buy, Sell, or Hold Post Q2 Earnings?

Medpace (MEDP): Buy, Sell, or Hold Post Q2 Earnings? Medpace currently trades at $610.21 and has been a dream stock for shareholders. It's returned 238% since August 2021, more than tripling the S&P 500's 70.1% gain. The company has also... Full story

Yahoo Finance • 2 months ago

CON vs. MEDP: Which Stock Should Value Investors Buy Now?

Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer... Full story

Yahoo Finance • 2 months ago

What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock

August J. Troendle, President & CEO of Medpace Holdings, Inc. (NASDAQ:MEDP), sold 15,978 shares of common stock in a transaction valued at $10.0 million. SEC Form 4 filing Transaction summary Metric Value Transaction value $10.0 million... Full story

Yahoo Finance • 2 months ago

2 Mid-Cap Stocks Worth Your Attention and 1 We Question

2 Mid-Cap Stocks Worth Your Attention and 1 We Question Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corpora... Full story

Yahoo Finance • 2 months ago

ZBH's Q2 Earnings Beat, '26 View Raised, Stock Up in Pre-Market

Zimmer Biomet Holdings, Inc. ZBH posted second-quarter 2026 adjusted earnings per share of $2.07, which beat the Zacks Consensus Estimate of $2.01 by 2.99%. The adjusted figure was unchanged year over year. The quarter's adjustments inclu... Full story

Yahoo Finance • 2 months ago

3 Cash-Heavy Stocks on Our Watchlist

3 Cash-Heavy Stocks on Our Watchlist Companies with more cash than debt often have stronger financial flexibility, making them attractive in uncertain markets. With interest payments less of a worry, these businesses can invest more in gr... Full story

Yahoo Finance • 3 months ago

Medpace Holdings Inc (MEDP) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Record ...

This article first appeared on GuruFocus. Revenue: $707.3 million in Q2 2026, a 17.2% year-over-year increase. Year-to-Date Revenue: $1.41 billion, up 21.7%. EBITDA: $153.4 million in Q2 2026, a 17.6% increase from Q2 2025. EBITDA Margin:... Full story

Yahoo Finance • 3 months ago

Stock Indexes Mixed Ahead of Alphabet’s Earnings

The S&P 500 Index ($SPX) (SPY) today is down -0.09%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.10%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.29%.  September E-mini S&P futures (ESU26) are down -0.07%, and September E... Full story

Yahoo Finance • 3 months ago

Stock Indexes Retreat as Crude Oil and Bond Yields Climb

The S&P 500 Index ($SPX) (SPY) today is down -0.13%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.15%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.48%.  September E-mini S&P futures (ESU26) are down -0.10%, and September E... Full story

Yahoo Finance • 3 months ago

Medpace To Report Q2 Results; Can Growth Sustain After A Strong Start To 2026?

(RTTNews) - Medpace Holdings, Inc. (MEDP) will report second-quarter 2026 results on July 22, 2026, with investors watching whether the contract research organization can extend the robust growth it delivered in Q1 and maintain its elevate... Full story

Yahoo Finance • 4 months ago

2 Healthcare Stocks to Consider Right Now and 1 We Brush Off

2 Healthcare Stocks to Consider Right Now and 1 We Brush Off From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited f... Full story

Yahoo Finance • 4 months ago

Medpace (MEDP) Stock Weighing Modest Undervaluation Against Rich P/E And Mixed Momentum

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Medpace Holdings (MEDP) has drawn investor attention after recent share price moves, with the stock roughly flat over the p... Full story

Yahoo Finance • 4 months ago

Charles River Labs (CRL) Pulled Back Due to AI Disruption Fears

Madison Small Cap Fund, managed by Madison Funds, released its Q1 2026 investor letter. A copy of the letter is available to download here. The Madison Small Cap Fund (class I) increased by 0.10% in the first quarter, trailing behind the R... Full story

Yahoo Finance • 4 months ago

Madison Small Cap Fund Increased Medpace Holdings (MEDP), Downplaying AI Fears

Madison Small Cap Fund, managed by Madison Funds, released its Q1 2026 investor letter. A copy of the letter is available to download here. The Madison Small Cap Fund (class I) increased by 0.10% in the first quarter, trailing behind the R... Full story